Category: Parry
-
Numinus Wellness (NUMI.V) to partner on MDMA psychotherapy trial for PTSD patients
If this was a 1990’s news website we’d be putting all sorts of animated siren gifs all over the top of this piece because, I ain’t gonna lie: It’s a big one. Numinus Wellness (NUMI.V), who we’ve been eyeing at a distance for some time because we love shrooms as an industry but don’t trust…
-
Plurilock (PLUR.V) uses AI and your keyboard typing patterns to ensure ongoing identification and network security
Even in a corporate environment where everyone is working out of the same office, network security is a pain in the ass. Logins and password changes and IP addresses and VPNs and lockouts and long calls to annoyed support staff all make for an awkward process of establishing who exactly is sitting at the keyboard.…
-
The rise of FansUnite (FANS.C) is a profit superspreader event
If you’ve been close to a company as it’s gone public, you’ll have no doubt experienced the issue for yourself: Someone, somewhere, who got in early and cheaply decides to break ranks with the other founders and deal guys, and dumps their shares the first chance they get. There are several problems with this, not…
-
Cannabis extractor Pure Extracts (PULL.C) stakes claim in the rocketing mushroom space
Barely a few weeks after telling the Equity.Guru audience that the timeline on mushrooms would see Pure Extracts (PULL.C) focusing on its core cannabis market, evolving market dynamics and a renewed focus on the potential of psychedelics have seen the company hit the gas on its long term shroom plans. With interest in functional and…
-
FansUnite (FANS.C) flying hard, a three-week three-bagger as revenues leap
FansUnite (FANS.C) is the star of the junior exchanges these past few weeks, accelerating hard on the back of good financial news earlier this month, to be up some 200% in three weeks. The run has seen stock in the company move from a 52-week low of $0.185 up to $0.57 today, with trading volume…
-
Delic Holdings (DELC.C) emerges as a psychedelics play aimed at executing real, legal business, and right now
Smallcap investors largely see the psychedelics space in one of two ways; you’re either in the ‘this may be big one day but there’s not a lot of fat on the bones just yet so I’ll wait’ camp, or the ‘fat schmat, everything is a trade and who cares about tomorrow’ camp. I’m pegged pretty…
-
Pure Extracts (PULL.C) goes public with profit-focused cannabis (and mushroom) extraction business model
Yeah, I know, I know. Canadian cannabis companies are ass right now, and have been for a few years. Trust me, I’m about as out of the LP business now as I’ve ever been, but you’d also be an idiot to tar every cannabis company with the same brush, because not every deal involves growing…
-
Brigadier Gold (BRG.V) sees rich veins extending in early results of new drilling program
If you’ve ever watched the litany of gold mining programs on cable TV’s reality TV channels, you’ve seen folks jumping up and down like they have a weasel in their pants whenever they hit enough gold to cast a teenager’s valentine pendant. “OMG IT’S A BEAUTY!” will cry some rough around the edges Australian with…
-
Revive Therapeutics (RVV.C) to have 10 clinical COVID-19 FDA trial sites by end of year
Earlier this year, when Revive Therapeutics (RVV.C) announced they had some pharma IP that may be relevant to the treatment of COVID-19, plenty of folks laughed uproariously at the thought that a three time loser might be relevant in 2020. Having missed on an earlier pharma focus, and come to the cannabis party a little…